Researchers have identified acute transverse myelitis (ATM) in a number of COVID-19 patients. ATM, which is marked by inflammation of the spinal cord, is a rare neurological disorder that can lead to spinal cord lesions, paralysis, and bowel dysfunction.
Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.
Airway hyperresponsiveness in asthma induced by methacholine is partly due to mast cells, a new study reports.
Since 2010, there has been an absolute rise in mortality for adults without a college degree. For those with higher education experience, mortality rates have decreased during the same time period.
Study reveals a significant number of COVID-19 survivors suffer from a range of neuropsychological and cognitive problems following recovery. Coronavirus survivors report experiencing PTSD, depression, memory impairments, and attention impairments upon recovery from the virus.
More than 80% of patients nearing the end of life reported experiencing dreams that were vivid, meaningful, and transformative. Patients reported the dreams made them feel supported, reassured and helped them to accept their impending death.
A new, lasting consequence of COVID-19 infection has been identified. Researchers report they have identified significant abnormalities in the eyes of those with severe coronavirus infection.
Middle-aged people who experienced mental health problems during youth aged at a faster pace, showed greater declines in sensory, motor, and cognitive functions, and were rated as looking older than their peers.
Many patients report symptoms of "brain fog" and confusion as a result of COVID-19 infection. Researchers report inflammatory molecules in the cerebral spinal fluid could be the cause of brain fog associated with coronavirus. Anti-inflammatory drugs, such as steriods, could help alleviate the symptoms of COVID brain.
··5 min read
A new AI system is not only able to analyze potential new variants of COVID-19, it can also vaccine design cycles within minutes, researchers report.